Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. - Wikidata - wikimedia - TriplyDB

Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B.

Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B.

http://www.wikidata.org/entity/Q36308206

about

Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders Salvianolic acid B reverses the epithelial-to-mesenchymal transition of HK-2 cells that is induced by transforming growth factor-β Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells Evolving therapies for liver fibrosis.A solid-phase extraction method for high-performance liquid chromatographic determination of salvianolic acid B in rabbit plasma: application to pharmacokinetic study.Biological analysis of herbal medicines used for the treatment of liver diseases.Salvianolic Acid B Inhibits ERK and p38 MAPK Signaling in TGF-β1-Stimulated Human Hepatic Stellate Cell Line (LX-2) via Distinct Pathways Chinese medicines as a resource for liver fibrosis treatment Experimental study of effect of Ganyanping on fibrosis in rat livers.Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation.Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.Salvianolic Acid B reducing portal hypertension depends on macrophages in isolated portal perfused rat livers with chronic hepatitis.Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation.Salvianolic Acid B Attenuates Experimental Pulmonary Fibrosis through Inhibition of the TGF-β Signaling Pathway.Effect of Fuzheng Huayu formula and its actions against liver fibrosis.Pay attention to the study on active antiliver fibrosis components of Chinese herbal medicine.Fuzheng huayu capsule in the treatment of liver fibrosis: clinical evidence and mechanism of action.Pathogenesis of liver cirrhosis.Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis.Antifibrotic therapies in the liver.A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives.Salvianolic acid B inhibits mitochondrial dysfunction by up-regulating mortalin.Novel anti-infective potential of salvianolic acid B against human serious pathogen Neisseria meningitidis.Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles.The inhibitory effect of salvianolic acid B on TGF-β1-induced proliferation and differentiation in lung fibroblasts.Salvianolic acid B attenuates hepatocyte apoptosis by regulating mediators in death receptor and mitochondrial pathways.Down-regulation of CD40 gene expression and inhibition of apoptosis with Danshensu in endothelial cells.SALVIANOLIC ACID B ALLEVIATING MYOCARDIUM INJURY IN ISCHEMIA REPERFUSION RATS.Expression of RNase H of human hepatitis B virus polymerase in Escherichia coli.Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms.Salvianolic acid B inhibits low-density lipoprotein oxidation and neointimal hyperplasia in endothelium-denuded hypercholesterolaemic rabbits.Liquid chromatography mass spectrometry for the determination of salvianolic acid B, a natural compound from the herb Danshen in rat plasma and application to pharmacokinetic study.Drugs and Targets in Fibrosis.

P2860

Q21284189-5CF213A1-97FC-4A78-AF0E-107334A6D72B Q26825621-1D3C3E6F-F5CB-4E22-9C65-B8E287581060 Q26992265-5BC6ED52-4665-443C-8437-ECC0CCC1679B Q28236906-4CF27F5C-A0F1-4273-B12E-3A9CBBBB59CF Q30369750-3FEB5C17-0DC9-4D8D-98B8-2519A34F81C5 Q30539166-0790C543-C302-416D-8AA9-E8B95E01BFE1 Q33269113-059882D1-8F5F-411F-9614-9A7F85CE9A51 Q33785052-80810A53-9F0B-4DB7-987F-E47119DC4631 Q35163498-B41711B9-7D6F-4292-9DB7-8B26B5E2A559 Q35575460-E76205F2-D094-431F-AEE8-0876CC64231B Q36179847-253B682C-A5EC-4A08-9BAB-E3F119020AE1 Q36232847-CBB701FB-2C87-4EB7-8BAE-892D490E445C Q36242106-A59A2D42-5B1A-468A-B8A8-3805F9DA6058 Q36345842-45227EEE-0B68-46FF-8DCE-30A97269B530 Q36456025-A710954B-7491-4CC9-9673-009B84DFF829 Q36474696-B677D4F3-FC94-4A2F-A1C6-525A0021253C Q36729351-B96970A0-CD68-47C0-A3B5-2970147A23CD Q36909491-1FE9E5AB-66CA-4B41-A59C-240D94D2DEFD Q36986125-1305C6D6-2E88-4E3A-9A8E-221BA48BBD4F Q37289563-3FDA59E5-6D55-4D5C-B2A3-06024F1E10B3 Q37995976-10E46642-2ED8-42E4-97F4-9805360467B4 Q37995977-B36A96F9-B1F1-4E5D-9C65-1E8AB795FA84 Q38223369-5B37E451-6A43-41D9-9418-8530B40F8411 Q38326327-4551E3F2-A563-4ABF-847B-4B0ACE4AA96B Q38480164-9A0AC7DD-E899-4439-82F7-4A9A703EF66C Q38588143-444FA5C1-F19B-440A-84C6-7227F3CC82A8 Q38714228-4CADE031-63D9-457F-A18F-D9E9B0408BCA Q38804347-82D07A69-5B15-4EDF-9E87-84F2399A00B9 Q38834366-2C57A59E-4192-4EA9-8A5C-92C5C2BCECE6 Q39011632-C7759462-84ED-40D0-B26D-6EE4793C1EEC Q39704562-C3217CCB-5374-44FF-B6B4-EAF34B41889C Q39907191-1841A3C3-D2E7-4C54-B942-A4D1F6C768ED Q41481781-EA3FB163-FD7B-46B5-87ED-CF151E909473 Q41813550-E04A4EC6-E7BA-4610-8629-84B17714084C Q42123715-3EC17093-DDA4-4ED0-A423-BA8030109D5D Q42591676-B121E2C8-66C6-4729-9D70-610D0F1922C7 Q43206635-CAEBB4D5-FF24-4D94-B75A-EF89A14249BE Q45855162-89CCE6C4-61E2-4472-AC0D-47AF840216D2 Q46010811-7E8BD992-30BF-48BE-9512-7D441A362558 Q47119118-52336197-7A2F-4089-A4CC-8C04C0572027

P2860

Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B.

http://www.wikidata.org/entity/Q36308206

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Clinical observation of salvia ...... brosis in chronic hepatitis B.

@ast

Clinical observation of salvia ...... brosis in chronic hepatitis B.

@en

type

label

Clinical observation of salvia ...... brosis in chronic hepatitis B.

@ast

Clinical observation of salvia ...... brosis in chronic hepatitis B.

@en

prefLabel

Clinical observation of salvia ...... brosis in chronic hepatitis B.

@ast

Clinical observation of salvia ...... brosis in chronic hepatitis B.

@en

P1433

Q36308206-B1FF8686-D6B1-40E4-AB4C-435E24D23002

P1476

Q36308206-F5B33CA4-4586-4835-A841-56E1FF70B426

P2093

Q36308206-1D48E7B6-3DDA-4E2F-BE13-9B60FE7D00E7

Q36308206-1DAA4C61-018E-4A85-BF7F-174C06108A62

Q36308206-3CEE192C-5284-4D02-B32B-D5B4CA4954D8

Q36308206-5447DBF4-2BA7-4DA3-8F1F-69BA73CBEDC5

Q36308206-597A68A1-BDB8-49B7-B918-0093301FEC13

Q36308206-8C14526E-8AF4-4B14-B78E-7F5FE7334068

Q36308206-8E532EE3-7AA9-4FCE-9F7A-46C4AF84745C

Q36308206-9594C4D8-8608-4D41-8BEB-991E72DE291F

Q36308206-A522A94B-3783-434B-8823-20D08A019EFD

Q36308206-BF625EAE-E5D9-4875-93DF-41606AA4F453

P2860

Q36308206-3A6C5E36-75B4-4262-8A39-DFBF709F898F

Q36308206-3F731D69-976C-4D2E-B5C9-57E3327015CB

Q36308206-4A5CAD2E-15AD-4337-860B-5CAEAD25DC82

Q36308206-4CBB4D5C-6A41-46CA-9BCF-A8D2A912ACFF

Q36308206-5012AC43-EB70-443E-B721-8D83949AD086

Q36308206-5195498E-515E-4BE0-845E-FC0E8565D1D0

Q36308206-55B31F66-ABA6-430A-95B3-5406629EC6CA

Q36308206-561E0E41-F3B6-436E-9692-71020903EE47

Q36308206-5670FCC9-FC32-481C-9F41-EF953BA6F47C

Q36308206-608446EE-8D8C-49A0-BF73-74A3A4798A71

P304

Q36308206-9FB00F40-FA94-4180-A056-D236556DC5FD

P31

Q36308206-D1CC9B7A-6CE3-49B4-99BD-EFA904E29EEE

P356

Q36308206-4B7024C9-B9F8-42E8-8A8F-AFE990F97840

P407

Q36308206-8399BD55-59D8-4562-A2F2-DF00375A3D5C

P433

Q36308206-72B30F8A-B0B1-43F4-9B7E-DAD005D2075C

P478

Q36308206-7A6677B0-84A0-4BE9-B0EB-99BAC2979661

P577

Q36308206-642DC013-D4DE-41C6-9293-6E07C2F4356D

P5875

Q36308206-4CC9BB33-A4B7-4401-9C88-9E7BBE7239C8

P698

Q36308206-3772F7E5-74D0-4A25-9F6D-1EE076B63E40

P932

Q36308206-38187C56-314D-4323-B56C-F35D065BD1DA

P356

P1433

World Journal of Gastroenterology

P1476

Clinical observation of salvia ...... brosis in chronic hepatitis B.

@en

P2093

Cheng Liu

http://www.w3.org/2001/XMLSchema#string

Cheng-Hai Liu

http://www.w3.org/2001/XMLSchema#string

Da-Yuan Zhu

http://www.w3.org/2001/XMLSchema#string

Hong-Tu Gu

http://www.w3.org/2001/XMLSchema#string

Hui-Ming Xue

http://www.w3.org/2001/XMLSchema#string

Lie-Ming Xu

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

Yi-Yang Hu

http://www.w3.org/2001/XMLSchema#string

Zhi-Qiang Xu

http://www.w3.org/2001/XMLSchema#string

Zhi-Qing Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride

Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study

Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.

Predicting the liver histology in chronic hepatitis C: how good is the clinician?

Treatment of hepatitis C related thrombocytopenia with interferon alpha.

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Is liver fibrosis reversible?

New aspects of hepatic fibrosis.

Liver fibrosis and altered matrix synthesis.

Extracellular matrix degradation and the role of hepatic stellate cells.

P304

679-685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V8.I4.679

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11213519

http://www.w3.org/2001/XMLSchema#string

P698

12174378

http://www.w3.org/2001/XMLSchema#string

P932

4656320

http://www.w3.org/2001/XMLSchema#string